Last 12 months
Inside the activity.
0 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 21, 2022 Filed Feb 23, 2022 21:30 UTC |
Moriarty Thomas MEVP & General Counsel
|
GrantCommon Stock | 572,542 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006300 · form4.xml · nonDerivative · entry 1 Moriarty Thomas M · CIK 0001412221 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 621,821 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on August 30, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:32 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
GrantCommon Stock | 322,395 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006308 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,024.717 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 21, 2022 Filed Feb 23, 2022 21:33 UTC |
Shah Prem SEVP and Co-President of Retail
|
GrantCommon Stock | 47,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-006310 · form4.xml · nonDerivative · entry 1 Shah Prem S · CIK 0001900910 · EVP and Co-President of Retail 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,620.24 F1 · shares: Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 21:42 UTC |
LUDWIG EDWARD JDirector
|
PurchaseCommon Stock | 1,000 | $105.90 | $105,904.40 |
DisclosureSEC source: 0001127602-22-004581 · form4.xml · nonDerivative · entry 1 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,334 Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 21:46 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 47,937 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-003406 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,937 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 21:46 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 47,937 | $110.00 | $5,273,070.00 |
DisclosureSEC source: 0001127602-22-003406 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,246.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| February 03, 2022 Filed Feb 4, 2022 21:46 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 47,937 | $102.26 | $4,902,037.62 |
DisclosureSEC source: 0001127602-22-003406 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,183.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:20 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Exercise / conversionStock Option · Derivative | 21,386 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-002958 · form4.xml · derivative · entry 6 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,386 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:20 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
SaleCommon Stock | 21,386 | $106.50 | $2,277,566.23 |
DisclosureSEC source: 0001127602-22-002958 · form4.xml · nonDerivative · entry 2 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,341.3689 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| February 01, 2022 Filed Feb 2, 2022 21:20 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Exercise / conversionCommon Stock | 21,386 | $102.26 | $2,186,932.36 |
DisclosureSEC source: 0001127602-22-002958 · form4.xml · nonDerivative · entry 1 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,727.3689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 21:43 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Exercise / conversionStock Option · Derivative | 6,059 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-002777 · form4.xml · derivative · entry 4 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,059 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options became exercisable in four equal annual installments beginning on 4/1/2016. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 21:43 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
SaleCommon Stock | 6,059 | $109.00 | $660,431.00 |
DisclosureSEC source: 0001127602-22-002777 · form4.xml · nonDerivative · entry 2 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,497.2554 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 21:43 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Exercise / conversionCommon Stock | 6,059 | $102.26 | $619,593.34 |
DisclosureSEC source: 0001127602-22-002777 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,556.2554 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 21:58 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
Exercise / conversionStock Option · Derivative | 68,482 | $0.00 Strike: $102.26 | $0.00 |
DisclosureSEC source: 0001127602-22-002431 · form4.xml · derivative · entry 6 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 68,482 shares Expires 2022-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2016. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 21:58 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
SaleCommon Stock | 68,482 | $107.50 | $7,361,815.00 |
DisclosureSEC source: 0001127602-22-002431 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,114.717 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| January 27, 2022 Filed Jan 28, 2022 21:58 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 68,482 | $102.26 | $7,002,969.32 |
DisclosureSEC source: 0001127602-22-002431 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,596.717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2021 Filed Dec 28, 2021 22:04 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
Tax withholdingCommon Stock (restricted) | 200 | $88.78 | $17,756.00 |
DisclosureSEC source: 0001127602-21-031962 · form4.xml · nonDerivative · entry 1 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,827 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 21:32 UTC |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock (restricted) | 68 | $88.78 | $6,037.04 |
DisclosureSEC source: 0001127602-21-030254 · form4.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,921 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| December 01, 2021 Filed Oct 14, 2022 21:52 UTC Amendment |
Clark James DavidSVP, Cont & Chief Acct Officer
|
Tax withholdingCommon Stock (restricted) | 266 | $88.78 | $23,615.48 |
DisclosureSEC source: 0001127602-22-023944 · form4a.xml · nonDerivative · entry 1 Clark James David · CIK 0001757584 · SVP, Cont & Chief Acct Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,723 F1 · kind: Transaction represents the withholding of shares by the Issuer to satisfy FICA taxes arising from the reporting person being retirement eligible. Read SEC document |
| November 28, 2021 Filed Dec 1, 2021 21:28 UTC |
Lynch Karen SDirector · President and CEO
|
Tax withholdingCommon Stock | 14,121 | $91.52 | $1,292,353.92 |
DisclosureSEC source: 0001127602-21-029913 · form4.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,114 F1 · kind: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock unit award. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:38 UTC |
WHITE TONY LDirector
|
GrantCommon Stock | 1,314 | $92.73 | $121,847.22 |
DisclosureSEC source: 0001127602-21-029708 · form4.xml · nonDerivative · entry 1 WHITE TONY L · CIK 0001171315 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,814 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:39 UTC |
SCHAPIRO MARY LDirector
|
GrantShare Credits · Derivative | 1,253.6396 | $92.73 Strike: $0.00 | $116,250.00 |
DisclosureSEC source: 0001127602-21-029709 · form4.xml · derivative · entry 2 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,638.1248 Underlying: Common Stock · 1,253.6396 shares Expires not disclosed F2 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F3 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F3 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:39 UTC |
SCHAPIRO MARY LDirector
|
GrantCommon Stock | 417 | $92.73 | $38,668.41 |
DisclosureSEC source: 0001127602-21-029709 · form4.xml · nonDerivative · entry 1 SCHAPIRO MARY L · CIK 0001192486 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,585 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:40 UTC |
MILLON JEAN PIERREDirector
|
GrantCommon Stock | 1,253 | $92.73 | $116,190.69 |
DisclosureSEC source: 0001127602-21-029710 · form4.xml · nonDerivative · entry 1 MILLON JEAN PIERRE · CIK 0001190016 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,253 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:42 UTC |
DORMAN DAVID WDirector
|
GrantCommon Stock | 3,154 | $92.73 | $292,470.42 |
DisclosureSEC source: 0001127602-21-029712 · form4.xml · nonDerivative · entry 1 DORMAN DAVID W · CIK 0001082870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,824 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:41 UTC |
Finucane Anne A.Director
|
GrantCommon Stock | 1,314 | $92.73 | $121,847.22 |
DisclosureSEC source: 0001127602-21-029711 · form4.xml · nonDerivative · entry 1 Finucane Anne A. · CIK 0001511491 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,314 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:43 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 1,334 | $92.73 | $123,701.82 |
DisclosureSEC source: 0001127602-21-029713 · form4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,402 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:44 UTC |
AGUIRRE FERNANDODirector
|
GrantCommon Stock | 1,253 | $92.73 | $116,190.69 |
DisclosureSEC source: 0001127602-21-029714 · form4.xml · nonDerivative · entry 1 AGUIRRE FERNANDO · CIK 0001224983 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,244 F1 · shares: Consists of common stock issued in payment of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:45 UTC |
WELDON WILLIAM CDirector
|
GrantShare Credits · Derivative | 1,671.5195 | $92.73 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-21-029715 · form4.xml · derivative · entry 2 WELDON WILLIAM C · CIK 0001189019 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,361.0307 Underlying: Common Stock · 1,671.5195 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:46 UTC |
LUDWIG EDWARD JDirector
|
GrantShare Credits · Derivative | 1,354.7396 | $92.73 Strike: $0.00 | $125,625.00 |
DisclosureSEC source: 0001127602-21-029716 · form4.xml · derivative · entry 3 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,905.134 Underlying: Common Stock · 1,354.7396 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:47 UTC |
FARAH ROGER NDirector
|
GrantShare Credits · Derivative | 1,671.5195 | $92.73 Strike: $0.00 | $155,000.00 |
DisclosureSEC source: 0001127602-21-029717 · form4.xml · derivative · entry 2 FARAH ROGER N · CIK 0001112072 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,899.2283 Underlying: Common Stock · 1,671.5195 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:48 UTC |
DECOUDREAUX ALECIA ADirector
|
GrantShare Credits · Derivative | 1,253.6396 | $92.73 Strike: $0.00 | $116,250.00 |
DisclosureSEC source: 0001127602-21-029718 · form4.xml · derivative · entry 2 DECOUDREAUX ALECIA A · CIK 0001233354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,051.6265 Underlying: Common Stock · 1,253.6396 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 17, 2021 Filed Nov 19, 2021 21:49 UTC |
BROWN C DAVID IIDirector
|
GrantShare Credits · Derivative | 1,779.3594 | $92.73 Strike: $0.00 | $165,000.00 |
DisclosureSEC source: 0001127602-21-029720 · form4.xml · derivative · entry 2 BROWN C DAVID II · CIK 0001197672 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,107.1262 Underlying: Common Stock · 1,779.3594 shares Expires not disclosed F1 · shares: Consists of share credits issued for deferral of a semi-annual retainer, at the market price, pursuant to the 2017 Incentive Compensation Plan. F2 · derivative.exercise_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. F2 · derivative.expiration_date: Consists of deferred stock compensation payable pursuant to Reporting Person's election. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:35 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
Exercise / conversionStock Option · Derivative | 108,870 | $0.00 Strike: $45.93 | $0.00 |
DisclosureSEC source: 0001127602-21-028481 · form4.xml · derivative · entry 7 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 108,870 shares Expires 2022-09-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 9/4/2015. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:35 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
SaleCommon Stock | 108,870 | $95.00 | $10,342,650.00 |
DisclosureSEC source: 0001127602-21-028481 · form4.xml · nonDerivative · entry 2 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,114.717 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:35 UTC |
Roberts Jonathan CEVP & Chief Operating Officer
|
Exercise / conversionCommon Stock | 108,870 | $45.93 | $5,000,399.10 |
DisclosureSEC source: 0001127602-21-028481 · form4.xml · nonDerivative · entry 1 Roberts Jonathan C · CIK 0001410515 · EVP & Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,984.717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:44 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 28,159 | $0.00 Strike: $58.34 | $0.00 |
DisclosureSEC source: 0001127602-21-028310 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,478 Underlying: Common Stock · 28,159 shares Expires 2030-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The number of shares subject to the option were calculated using a 30-day average price. F2 · derivative.exercise_date: Options became exercisable in four equal annual installments, commencing 4/1/2021. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:44 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 28,159 | $90.00 | $2,534,310.00 |
DisclosureSEC source: 0001127602-21-028310 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,246.059 Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 20:44 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 28,159 | $58.34 | $1,642,796.06 |
DisclosureSEC source: 0001127602-21-028310 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,405.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:34 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 80,802 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-21-027755 · form4.xml · derivative · entry 5 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,803 Underlying: Common Stock · 80,802 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2020. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:34 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 80,802 | $88.00 | $7,110,576.00 |
DisclosureSEC source: 0001127602-21-027755 · form4.xml · nonDerivative · entry 3 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,246.059 F1 · deemedExecutionDate: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:34 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 1,955 | $88.00 | $172,040.00 |
DisclosureSEC source: 0001127602-21-027755 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,048.059 Read SEC document |
| October 26, 2021 Filed Oct 28, 2021 20:34 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 80,802 | $54.19 | $4,378,660.38 |
DisclosureSEC source: 0001127602-21-027755 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,003.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 02, 2021 Filed Sep 7, 2021 23:57 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 2,625 | $87.00 | $228,375.00 |
DisclosureSEC source: 0000947871-21-000985 · ownership.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,201.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| August 05, 2021 Filed Aug 5, 2021 20:58 UTC |
LUDWIG EDWARD JDirector
|
PurchaseCommon Stock | 3,000 | $79.55 | $238,635.00 |
DisclosureSEC source: 0001127602-21-023166 · form4.xml · nonDerivative · entry 1 LUDWIG EDWARD J · CIK 0001221783 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,334 Read SEC document |
| June 28, 2021 Filed Jun 29, 2021 21:43 UTC |
Lotvin AlanEVP&President-PharmacyServices
|
SaleCommon Stock | 2,781 | $83.67 | $232,686.27 |
DisclosureSEC source: 0001127602-21-020816 · form4.xml · nonDerivative · entry 1 Lotvin Alan · CIK 0001472795 · EVP&President-PharmacyServices 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,047.6756 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:04 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionStock Option · Derivative | 65,681 | $0.00 Strike: $62.21 | $0.00 |
DisclosureSEC source: 0001127602-21-020199 · form4.xml · derivative · entry 4 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,894 Underlying: Common Stock · 65,681 shares Expires 2025-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Option became exercisable in four equal annual installments, commencing 4/1/2019. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:04 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
SaleCommon Stock | 67,552 | $86.00 | $5,809,472.00 |
DisclosureSEC source: 0001127602-21-020199 · form4.xml · nonDerivative · entry 2 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,826.059 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:04 UTC |
Brennan Troyen AEVP and Chief Medical Officer
|
Exercise / conversionCommon Stock | 65,681 | $62.21 | $4,086,015.01 |
DisclosureSEC source: 0001127602-21-020199 · form4.xml · nonDerivative · entry 1 Brennan Troyen A · CIK 0001351402 · EVP and Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,378.059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 20:48 UTC |
Finke Daniel PEVP/Pres, Health Care Benefits
|
Exercise / conversionStock Option · Derivative | 32,320 | $0.00 Strike: $54.19 | $0.00 |
DisclosureSEC source: 0001127602-21-019437 · form4.xml · derivative · entry 5 Finke Daniel P · CIK 0001844305 · EVP/Pres, Health Care Benefits 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,322 Underlying: Common Stock · 32,320 shares Expires 2029-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable in four equal annual installments, beginning on 4/1/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.